Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023

Upgrades

For Steel Dynamics Inc STLD, Citigroup upgraded the previous rating of Neutral to Buy. For the second quarter, Steel Dynamics had an EPS of $4.81, compared to year-ago quarter EPS of $6.73. The current stock performance of Steel Dynamics shows a 52-week-high of $136.46 and a 52-week-low of $69.12. Moreover, at the end of the last trading period, the closing price was at $101.10.

Citigroup upgraded the previous rating for Cleveland-Cliffs Inc CLF from Neutral to Buy. For the second quarter, Cleveland-Cliffs had an EPS of $0.69, compared to year-ago quarter EPS of $1.31. The stock has a 52-week-high of $22.83 and a 52-week-low of $11.82. At the end of the last trading period, Cleveland-Cliffs closed at $14.46.

For Quanterix Corp QTRX, Canaccord Genuity upgraded the previous rating of Hold to Buy. Quanterix earned $0.16 in the second quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $28.77 and a 52-week-low of $8.02. At the end of the last trading period, Quanterix closed at $25.01.

For Brookfield Infrastructure Partners LP BIP, Raymond James upgraded the previous rating of Outperform to Strong Buy. Brookfield Infr Partners earned $0.38 in the second quarter, compared to $0.13 in the year-ago quarter. The current stock performance of Brookfield Infr Partners shows a 52-week-high of $41.15 and a 52-week-low of $30.05. Moreover, at the end of the last trading period, the closing price was at $30.71.

According to Wedbush, the prior rating for CarMax Inc KMX was changed from Neutral to Outperform. For the first quarter, CarMax had an EPS of $1.16, compared to year-ago quarter EPS of $1.56. At the moment, the stock has a 52-week-high of $87.50 and a 52-week-low of $52.13. CarMax closed at $76.66 at the end of the last trading period.

Guggenheim upgraded the previous rating for Microsoft Corp MSFT from Sell to Neutral. In the fourth quarter, Microsoft showed an EPS of $2.69, compared to $2.23 from the year-ago quarter. The current stock performance of Microsoft shows a 52-week-high of $366.78 and a 52-week-low of $213.46. Moreover, at the end of the last trading period, the closing price was at $317.01.

Loop Capital upgraded the previous rating for Clearwater Analytics Holdings Inc CWAN from Hold to Buy. Clearwater Analytics Hldg earned $0.08 in the second quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $20.00 and a 52-week-low of $13.02. At the end of the last trading period, Clearwater Analytics Hldg closed at $19.67.

According to Citigroup, the prior rating for Sealed Air Corp SEE was changed from Neutral to Buy. In the second quarter, Sealed Air showed an EPS of $0.80, compared to $1.01 from the year-ago quarter. The current stock performance of Sealed Air shows a 52-week-high of $56.43 and a 52-week-low of $31.25. Moreover, at the end of the last trading period, the closing price was at $31.41.

B of A Securities upgraded the previous rating for Ermenegildo Zegna NV ZGN from Neutral to Buy. NoneAt the moment, the stock has a 52-week-high of $16.36 and a 52-week-low of $9.66. Ermenegildo Zegna closed at $13.72 at the end of the last trading period.

For AstraZeneca PLC AZN, Jefferies upgraded the previous rating of Hold to Buy. In the second quarter, AstraZeneca showed an EPS of $1.07, compared to $0.86 from the year-ago quarter. The current stock performance of AstraZeneca shows a 52-week-high of $76.56 and a 52-week-low of $52.66. Moreover, at the end of the last trading period, the closing price was at $67.83.

Morgan Stanley upgraded the previous rating for Novartis AG NVS from Underweight to Equal-Weight. In the second quarter, Novartis showed an EPS of $1.83, compared to $1.56 from the year-ago quarter. The stock has a 52-week-high of $105.61 and a 52-week-low of $74.09. At the end of the last trading period, Novartis closed at $101.14.

According to JP Morgan, the prior rating for Dow Inc DOW was changed from Neutral to Overweight. For the second quarter, Dow had an EPS of $0.75, compared to year-ago quarter EPS of $2.31. At the moment, the stock has a 52-week-high of $60.88 and a 52-week-low of $42.92. Dow closed at $50.25 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

According to Noble Capital Markets, the prior rating for Lifeway Foods Inc LWAY was changed from Outperform to Market Perform. In the second quarter, Lifeway Foods showed an EPS of $0.21, compared to $0.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.96 and a 52-week-low of $5.26. Lifeway Foods closed at $12.42 at the end of the last trading period.

For Quantum-Si Inc QSI, Canaccord Genuity downgraded the previous rating of Buy to Hold. For the second quarter, Quantum-Si had an EPS of $0.18, compared to year-ago quarter EPS of $0.23. At the moment, the stock has a 52-week-high of $3.90 and a 52-week-low of $1.36. Quantum-Si closed at $1.98 at the end of the last trading period.

For SomaLogic Inc SLGC, Canaccord Genuity downgraded the previous rating of Buy to Hold. In the second quarter, SomaLogic showed an EPS of $0.13, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.79 and a 52-week-low of $1.93. SomaLogic closed at $2.27 at the end of the last trading period.

Goldman Sachs downgraded the previous rating for Harmony Biosciences Holdings Inc HRMY from Neutral to Sell. In the second quarter, Harmony Biosciences showed an EPS of $0.76, compared to $0.57 from the year-ago quarter. The stock has a 52-week-high of $61.94 and a 52-week-low of $29.81. At the end of the last trading period, Harmony Biosciences closed at $36.28.

BTIG downgraded the previous rating for Morphic Holding Inc MORF from Buy to Neutral. For the second quarter, Morphic Holding had an EPS of $0.92, compared to year-ago quarter EPS of $0.68. At the moment, the stock has a 52-week-high of $63.08 and a 52-week-low of $23.13. Morphic Holding closed at $36.68 at the end of the last trading period.

Jefferies downgraded the previous rating for Urban Outfitters Inc URBN from Buy to Hold. In the second quarter, Urban Outfitters showed an EPS of $1.10, compared to $0.64 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.81 and a 52-week-low of $18.76. Urban Outfitters closed at $31.90 at the end of the last trading period.

Morgan Stanley downgraded the previous rating for Vaccitech PLC VACC from Overweight to Equal-Weight. In the second quarter, Vaccitech showed an EPS of $0.62, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.35 and a 52-week-low of $1.64. Vaccitech closed at $1.68 at the end of the last trading period.

For FMC Corp FMC, Redburn Atlantic downgraded the previous rating of Buy to Neutral. FMC earned $0.50 in the second quarter, compared to $1.93 in the year-ago quarter. The current stock performance of FMC shows a 52-week-high of $134.38 and a 52-week-low of $68.17. Moreover, at the end of the last trading period, the closing price was at $68.39.

Barclays downgraded the previous rating for Plains GP Holdings LP PAGP from Equal-Weight to Underweight. For the second quarter, Plains GP Holdings had an EPS of $0.25, compared to year-ago quarter EPS of $0.30. The current stock performance of Plains GP Holdings shows a 52-week-high of $16.70 and a 52-week-low of $10.45. Moreover, at the end of the last trading period, the closing price was at $16.61.

Barclays downgraded the previous rating for Plains All American Pipeline LP PAA from Equal-Weight to Underweight. For the second quarter, Plains All American had an EPS of $0.25, compared to year-ago quarter EPS of $0.30. At the moment, the stock has a 52-week-high of $16.05 and a 52-week-low of $10.17. Plains All American closed at $15.79 at the end of the last trading period.

Bernstein downgraded the previous rating for BHP Group Ltd BHP from Outperform to Market Perform. NoneThe current stock performance of BHP Group shows a 52-week-high of $71.52 and a 52-week-low of $46.92. Moreover, at the end of the last trading period, the closing price was at $56.75.

For Foot Locker Inc FL, Jefferies downgraded the previous rating of Buy to Hold. Foot Locker earned $0.04 in the second quarter, compared to $1.10 in the year-ago quarter. The stock has a 52-week-high of $47.22 and a 52-week-low of $14.84. At the end of the last trading period, Foot Locker closed at $17.76.

According to Jefferies, the prior rating for Nike Inc NKE was changed from Buy to Hold. Nike earned $0.66 in the fourth quarter, compared to $0.99 in the year-ago quarter. At the moment, the stock has a 52-week-high of $131.31 and a 52-week-low of $82.24. Nike closed at $90.85 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

With a Buy rating, Craig-Hallum initiated coverage on Solo Brands Inc DTC. The price target seems to have been set at $8.00 for Solo Brands. In the second quarter, Solo Brands showed an EPS of $0.22, compared to $0.40 from the year-ago quarter. The current stock performance of Solo Brands shows a 52-week-high of $8.86 and a 52-week-low of $3.39. Moreover, at the end of the last trading period, the closing price was at $4.51.

With a Buy rating, Argus Research initiated coverage on Choice Hotels International Inc CHH. The price target seems to have been set at $145.00 for Choice Hotels Intl. For the second quarter, Choice Hotels Intl had an EPS of $1.75, compared to year-ago quarter EPS of $1.43. The current stock performance of Choice Hotels Intl shows a 52-week-high of $136.02 and a 52-week-low of $104.20. Moreover, at the end of the last trading period, the closing price was at $121.24.

Benchmark initiated coverage on Taboola.com Ltd TBLA with a Buy rating. The price target for Taboola.com is set to $6.00. Taboola.com earned $0.00 in the second quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.45 and a 52-week-low of $1.52. Taboola.com closed at $3.74 at the end of the last trading period.

With a Buy rating, Alliance Global Partners initiated coverage on Vaccitech PLC VACC. The price target seems to have been set at $12.00 for Vaccitech. For the second quarter, Vaccitech had an EPS of $0.62, compared to year-ago quarter EPS of $0.41. The stock has a 52-week-high of $3.35 and a 52-week-low of $1.64. At the end of the last trading period, Vaccitech closed at $1.68.

UBS initiated coverage on Ziff Davis Inc ZD with a Neutral rating. The price target for Ziff Davis is set to $81.00. Ziff Davis earned $1.27 in the second quarter, compared to $1.58 in the year-ago quarter. The current stock performance of Ziff Davis shows a 52-week-high of $94.45 and a 52-week-low of $58.08. Moreover, at the end of the last trading period, the closing price was at $66.61.

UBS initiated coverage on TechTarget Inc TTGT with a Neutral rating. The price target for TechTarget is set to $31.00. In the second quarter, TechTarget showed an EPS of $0.45, compared to $0.68 from the year-ago quarter. The current stock performance of TechTarget shows a 52-week-high of $68.15 and a 52-week-low of $26.01. Moreover, at the end of the last trading period, the closing price was at $26.57.

With an Outperform rating, Wedbush initiated coverage on Pharvaris NV PHVS. The price target seems to have been set at $27.00 for Pharvaris. In the second quarter, Pharvaris showed an EPS of $0.69, compared to $0.40 from the year-ago quarter. The current stock performance of Pharvaris shows a 52-week-high of $26.86 and a 52-week-low of $1.80. Moreover, at the end of the last trading period, the closing price was at $20.32.

Needham initiated coverage on Upstart Holdings Inc UPST with a Hold rating. Upstart Hldgs earned $0.06 in the second quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $72.58 and a 52-week-low of $11.93. Upstart Hldgs closed at $26.55 at the end of the last trading period.

With a Buy rating, Canaccord Genuity initiated coverage on Hudson Technologies Inc HDSN. The price target seems to have been set at $15.00 for Hudson Technologies. For the second quarter, Hudson Technologies had an EPS of $0.41, compared to year-ago quarter EPS of $0.59. The current stock performance of Hudson Technologies shows a 52-week-high of $13.34 and a 52-week-low of $6.62. Moreover, at the end of the last trading period, the closing price was at $12.10.

With a Buy rating, HSBC initiated coverage on Plug Power Inc PLUG. The price target seems to have been set at $11.00 for Plug Power. Plug Power earned $0.40 in the second quarter, compared to $0.30 in the year-ago quarter. The stock has a 52-week-high of $25.50 and a 52-week-low of $7.33. At the end of the last trading period, Plug Power closed at $7.43.

With a Buy rating, HC Wainwright & Co. initiated coverage on AngioDynamics Inc ANGO. The price target seems to have been set at $19.00 for AngioDynamics. In the fourth quarter, AngioDynamics showed an EPS of $0.02, compared to $0.01 from the year-ago quarter. The current stock performance of AngioDynamics shows a 52-week-high of $21.86 and a 52-week-low of $6.71. Moreover, at the end of the last trading period, the closing price was at $7.02.

UBS initiated coverage on The Chefs' Warehouse Inc CHEF with a Buy rating. The price target for The Chefs' Warehouse is set to $37.00. In the second quarter, The Chefs' Warehouse showed an EPS of $0.35, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $39.50 and a 52-week-low of $22.30. At the end of the last trading period, The Chefs' Warehouse closed at $23.26.

UBS initiated coverage on Warby Parker Inc WRBY with a Neutral rating. The price target for Warby Parker is set to $13.00. In the second quarter, Warby Parker showed an EPS of $0.04, compared to $0.01 from the year-ago quarter. The stock has a 52-week-high of $18.97 and a 52-week-low of $9.50. At the end of the last trading period, Warby Parker closed at $12.35.

With a Market Outperform rating, JMP Securities initiated coverage on Sana Biotechnology Inc SANA. The price target seems to have been set at $9.00 for Sana Biotechnology. For the second quarter, Sana Biotechnology had an EPS of $0.45, compared to year-ago quarter EPS of $0.47. The stock has a 52-week-high of $8.01 and a 52-week-low of $2.99. At the end of the last trading period, Sana Biotechnology closed at $3.83.

JMP Securities initiated coverage on Ambrx Biopharma Inc AMAM with a Market Outperform rating. The price target for Ambrx Biopharma is set to $15.00. In the second quarter, Ambrx Biopharma showed an EPS of $0.35, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.86 and a 52-week-low of $0.38. Ambrx Biopharma closed at $11.32 at the end of the last trading period.

Goldman Sachs initiated coverage on Alector Inc ALEC with a Sell rating. The price target for Alector is set to $4.00. Alector earned $0.02 in the second quarter, compared to $0.12 in the year-ago quarter. The current stock performance of Alector shows a 52-week-high of $10.03 and a 52-week-low of $4.98. Moreover, at the end of the last trading period, the closing price was at $6.88.

With a Neutral rating, Goldman Sachs initiated coverage on Fulcrum Therapeutics Inc FULC. The price target seems to have been set at $5.00 for Fulcrum Therapeutics. Fulcrum Therapeutics earned $0.38 in the second quarter, compared to $0.83 in the year-ago quarter. The current stock performance of Fulcrum Therapeutics shows a 52-week-high of $15.00 and a 52-week-low of $2.25. Moreover, at the end of the last trading period, the closing price was at $4.17.

For Maplebear Inc CART, Wolfe Research initiated coverage, by setting the current rating at Peer Perform. In the third quarter, Maplebear showed an EPS of $0.21, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $42.95 and a 52-week-low of $29.90. At the end of the last trading period, Maplebear closed at $30.00.

See all analyst ratings initiations.